8/8/2025AsiFlyer Secures New Funding to Propel Next‑Gen Botulinum Toxin

8/6/2025XTalPi Signs US$6 Billion Global Drug Discovery Deal with DoveTree

8/6/2025China's CGT Boom: NMPA's CDE and Tsinghua Team Publish Eight-Year Revi...

8/6/2025Chinese Private Biopharma Sees Surge in July Financing, Highest Since ...

8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...

8/5/2025Zenitar Raises ~CNY 400M to Accelerate AI-Driven Drug Discovery and O...

8/5/2025EMBIOS Secures Pre-A Funding to Advance First-in-Class Autoimmune Ther...

8/5/2025Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development

8/5/2025Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...

8/5/2025China Biopharma Licensing Deals Soar in July, Driven by $500M Hengrui-...

8/5/2025TenNor Files for Hong Kong IPO to Fund Breakthrough Antibacterial Prog...

8/5/2025Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...

8/5/2025Sanofi Withdraws Praluent from China Amid Strategic Shift

8/4/2025I-Mab Announces Pricing of $65M Underwritten Offering of ADS

8/2/2025Sumitomo Pharma Completes Divestiture of China Business to Marubeni Gr...

8/2/2025Attec Secures Strategic Series A Funding to Advance Protein Degrader P...

8/1/2025Mabgeek Clinches CNY 260M Pre‑IPO Boost and Advances MG‑K10 Commerc...

8/1/2025TenNor Therapeutics IPO Application Accepted by HKEX

8/1/2025Lepu Biopharma Licenses Two T‑Cell Engagers to Excalipoint

8/1/2025Everest Makes Strategic Equity Investment in I-Mab to Advance Oncology...

8/1/2025Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Cand...

8/1/2025China's Biotech Sector Faces Geopolitical Headwinds as Asia-Pacific Em...

8/1/2025Wuxi AppTec Raises Nearly US$1B in Hong Kong to Fuel Global Expansion

7/31/2025DarwinCell Breaks Ground with CNY 200M Series C Financing from Tsing C...

7/31/2025Ancocare Closes Series B Financing to Fuel Oncolytic Virus Pipeline E...

7/31/2025Leto Lab Secures Series D Financing Led by Hankang Capital

7/31/2025R&B Bio Secures New Funding Round Led by SBI Holdings

7/31/2025GE HealthCare Q2 Results Highlight Mixed Signals in China Amid Tariff ...

7/30/2025AstraZeneca's Lynparza Gains Approval for New Indication in China

7/30/2025J&J's Lazcluze Approved for NSCLC in China

Page:6/25 Total number of articles:735: [First][<<] [4] [5] [6] [7] [8] [>>] [End]